Literature DB >> 11381437

Late recurrence of neuroblastoma stage 4S with unusual clinicopathologic findings.

K Kato1, K Ishikawa, Y Toyoda, H Kigasawa, N Aida, T Nishi, T Kusafuka, J Hara , R Ijiri, Y Tanaka.   

Abstract

The authors present unusual clinicopathologic findings of a patient with neuroblastoma stage 4S that recurred 11 years after induction of complete remission with chemotherapy. A 12-year-old girl presented with recurrent tumor in the liver. Urinary catecholamine metabolites were within normal range in contrast to the increased values at initial presentation. She underwent left lateral segmentectomy and biopsy of the right lobe. Histologic analysis of the recurrent tumor showed undifferentiated neuroblastoma intermingled with mature ganglioneuromatous lesions. There also were scattered ganglioneuromatous lesions throughout nontumorous area of the liver. Although multimodal intensified treatments including autologous bone marrow transplantation were performed, the patient died of obstinate recurrent tumor at age 14 years. The clinicopathologic findings suggested dedifferentiation from the ganglioneuromatous lesion rather than ordinary recurrence of the primary tumor. The current case and the literature review may indicate that long-term follow-up would be necessary for neuroblastoma stage 4/4S cases. J Pediatr Surg 36:953-955. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11381437     DOI: 10.1053/jpsu.2001.24002

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Hepatic metastatic disease in pediatric and adolescent solid tumors.

Authors:  Israel Fernandez-Pineda; John A Sandoval; Andrew M Davidoff
Journal:  World J Hepatol       Date:  2015-07-18

2.  Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Karen Wasilewski-Masker; Qi Liu; Yutaka Yasui; Wendy Leisenring; Lillian R Meacham; Sue Hammond; Anna T Meadows; Leslie L Robison; Ann C Mertens
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 11.816

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.